Search

Your search keyword '"Ramanathan, Murali"' showing total 993 results

Search Constraints

Start Over You searched for: Author "Ramanathan, Murali" Remove constraint Author: "Ramanathan, Murali"
993 results on '"Ramanathan, Murali"'

Search Results

1. On Mitigating Code LLM Hallucinations with API Documentation

2. CodeFort: Robust Training for Code Generation Models

3. Repoformer: Selective Retrieval for Repository-Level Code Completion

5. Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study

6. Code-Aware Prompting: A study of Coverage Guided Test Generation in Regression Setting using LLM

8. CrossCodeEval: A Diverse and Multilingual Benchmark for Cross-File Code Completion

9. Exploring Continual Learning for Code Generation Models

10. A Static Evaluation of Code Completion by Large Language Models

14. Greener yet Powerful: Taming Large Code Generation Models with Quantization

16. ReCode: Robustness Evaluation of Code Generation Models

17. CoCoMIC: Code Completion By Jointly Modeling In-file and Cross-file Context

18. Multi-lingual Evaluation of Code Generation Models

19. A Study of Real-World Data Races in Golang

21. Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis

29. Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis.

30. Predictive Utility of Serum Protein Biomarkers from the Octave MSDA Panel for Optic Neuritis Events in People with Multiple Sclerosis (S42.008)

34. Variational autoencoders for generative modeling of drug dosing determinants in renal, hepatic, metabolic, and cardiac disease states.

35. Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis.

36. Human restricted CHRFAM7A gene increases brain efficiency.

37. Non‐neurological factors associated with serum neurofilament levels in the United States population.

38. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis

39. Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis

47. Plasma levels of soluble NCAM in multiple sclerosis

48. Algorithms for Efficient Mining of Statistically Significant Attribute Association Information

49. Modelling the progression of illicit substance use patterns from real‐world evidence.

Catalog

Books, media, physical & digital resources